About
3PBIOVIAN is a biopharmaceutical CDMO that provides development and manufacturing services for proteins, viral vectors, plasmid DNA, aseptic fill & finish, QC, and conjugated biotherapeutics. It supports biotech and pharma companies from early development through clinical and commercial supply. It has manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland, and a contact office in Boston, United States.
Services
Recombinant Protein Manufacturing Services
End-to-end recombinant protein manufacturing from early development to large-scale production.
Microbial Manufacturing Services
Microbial protein production using bacterial, yeast, and other microbial hosts from process development to GMP manufacturing.
Mammalian Manufacturing Services
Mammalian cell-based manufacturing for complex recombinant proteins and biologics from cell line development to GMP production.
Viral Vector Manufacturing Services
Integrated viral vector development and GMP manufacturing for gene therapy, vaccine, and advanced therapeutic programs.
AAV Manufacturing
Manufacturing of AAV vectors with GMP documentation and Qualified Person support.
Adenovirus Manufacturing
Manufacturing of adenovirus vectors for adherent or suspension-based processes.
Plasmid DNA Production
HQ and GMP plasmid DNA production for pre-clinical, clinical, and commercial projects.
Aseptic Fill & Finish
Integrated drug product services including formulation, aseptic filling, sterilization or aseptic processing, inspection, labeling, packaging, and QP-certified release.
CDMO: development & manufacturing
2 more services
- QC Services
- Conjugated Biotherapeutics
- What to send
- Service Interest
Capabilities
- Assays and studies
- Fill-finish
- AAV
- Process development
- Bioreactors
- E. coli expression
- CHO
9 more
- Antibodies
- Compendial analysis
- Microbiological analysis
- Product-specific assays
- Impurity analysis
- Cell-based assays
- Sterility testing
- Bioburden testing
- Endotoxin testing
- Scale and capacity
- Up to 200 L
- Typical batch sizes 200–1000 vials
- Therapeutic areas
- Gene therapy
- Vaccine development
- Biopharmaceuticals
Instruments and platforms
- Single-use bioreactors
- Packed-bed bioreactor
- Multilayer flasks
- Ultracentrifugation
- Chromatography
- Affinity Chromatography
4 more
- Anion Exchange Chromatography (AEX)
- Cation Exchange Chromatography (CEX)
- Tangential Flow Filtration (TFF)
- Automated aseptic filling line
Modalities and species
- Modalities
- Antibody
- Viral vector
- Cell therapy
- Recombinant protein
- Vaccine
- Plasmid DNA
- Species and models
- E. coli
- Yeast
- P. pastoris
- S. cerevisiae
- H. pylori
- S. noursei
5 more
- CHO
- NS0
- BHK-21
- HEK293
- Hybridoma
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: microbial manufacturing
Details
- Type
- CRDMO
- Team
- Over 20 countries
- Office
- 53 State Street Suites 503 & 504 Boston MA 02109 United States
- Sites
- Pamplona-Noáin, Spain
- Boston, United States
- Serves
- Europe, the US, Asia, worldwide